ResearcherGuiyang Medical UniversityActive in the last 2 years

Xi-zhuang Pan

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 7 November 2026

Known by name at one institution; no external author ID yet. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2025: 1 paper

Papers 1

DTL promotes pancreatic cancer progression through ubiquitin-mediated degradation of SMAD4. Co-author DOI 10.1016/j.ijbiomac.2025.148692 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Likun Ren · 1 shared paper, 2025 · strength 0.25
- Paper DTL promotes pancreatic cancer progression through ubiquitin-mediated degradation of SMAD4. DOI 10.1016/j.ijbiomac.2025.148692 ↗
Shaojie Chen · 1 shared paper, 2025 · strength 0.25
- Paper DTL promotes pancreatic cancer progression through ubiquitin-mediated degradation of SMAD4. DOI 10.1016/j.ijbiomac.2025.148692 ↗
Yaozhen Pan · 1 shared paper, 2025 · strength 0.25
- Paper DTL promotes pancreatic cancer progression through ubiquitin-mediated degradation of SMAD4. DOI 10.1016/j.ijbiomac.2025.148692 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.